Scarica l'app Stockscreener
18.48
3.24%
0.58
Precedente Chiudi:
$17.90
Aprire:
$17.77
Volume 24 ore:
566.46K
Relative Volume:
1.31
Capitalizzazione di mercato:
$936.43M
Reddito:
$62.02M
Utile/perdita netta:
$-45.65M
Rapporto P/E:
-20.09
EPS:
-0.92
Flusso di cassa netto:
$-9.60M
1 W Prestazione:
+6.27%
1M Prestazione:
+31.91%
6M Prestazione:
+96.39%
1 anno Prestazione:
+92.30%
Intervallo 1D:
$17.50
$18.57
Intervallo di 1 settimana:
$17.25
$18.58
Portata 52W:
$7.90
$18.96
Theravance Biopharma Inc Stock (TBPH) Company Profile
Nome
Theravance Biopharma Inc
Settore
Industria
Telefono
650-808-6000
Indirizzo
UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN
Confronta TBPH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TBPH
Theravance Biopharma Inc
|
18.48 | 907.04M | 62.02M | -45.65M | -9.60M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Theravance Biopharma Inc Stock (TBPH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-12 | Iniziato | B. Riley Securities | Buy |
| 2024-08-06 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-04-12 | Iniziato | BTIG Research | Buy |
| 2024-01-08 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-05-23 | Iniziato | SVB Leerink | Outperform |
| 2021-11-05 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2021-09-15 | Downgrade | JP Morgan | Overweight → Underweight |
| 2021-08-25 | Downgrade | Morgan Stanley | Overweight → Underweight |
| 2021-08-24 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-10-14 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-07 | Iniziato | JP Morgan | Overweight |
| 2020-06-15 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-05-13 | Iniziato | Cowen | Outperform |
| 2020-01-08 | Reiterato | H.C. Wainwright | Buy |
| 2019-11-06 | Aggiornamento | Robert W. Baird | Underperform → Neutral |
| 2019-10-29 | Iniziato | H.C. Wainwright | Buy |
| 2018-03-29 | Ripresa | Piper Jaffray | Overweight |
| 2017-08-17 | Iniziato | Evercore ISI | Outperform |
| 2017-06-16 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-05-11 | Reiterato | Needham | Buy |
| 2016-12-21 | Iniziato | Needham | Buy |
| 2016-11-03 | Iniziato | Piper Jaffray | Overweight |
| 2016-10-12 | Downgrade | Robert W. Baird | Neutral → Underperform |
| 2016-08-03 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2016-06-20 | Iniziato | Guggenheim | Buy |
| 2016-06-20 | Reiterato | Leerink Partners | Outperform |
| 2016-05-12 | Iniziato | Leerink Partners | Outperform |
| 2016-05-05 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2015-02-03 | Aggiornamento | Robert W. Baird | Underperform → Neutral |
Mostra tutto
Theravance Biopharma Inc Borsa (TBPH) Ultime notizie
Theravance's Q3 Earnings Surpass Estimates, Revenues Match - MSN
[Form 4] Theravance Biopharma, Inc. Insider Trading Activity - Stock Titan
CEO Winningham Surrenders 56,817 Of Theravance Biopharma Inc [TBPH] - TradingView
Can Theravance Biopharma Inc. stock beat analyst upgrades - newser.com
Why pension funds invest in Theravance Biopharma Inc. (0TB) stock2025 Growth vs Value & AI Based Buy/Sell Signal Reports - newser.com
Is Theravance Biopharma Inc. stock attractive for passive investors2025 Technical Patterns & Risk Controlled Swing Alerts - newser.com
Theravance Biopharma (TBPH) is a Top-Ranked Growth Stock: Should You Buy? - MSN
Why Theravance Biopharma Inc. stock is rated strong buy2025 Fundamental Recap & Accurate Trade Setup Notifications - newser.com
Theravance Biopharma to host virtual KOL event on ampreloxetine study - Investing.com
Theravance Biopharma to host virtual KOL event on ampreloxetine study By Investing.com - Investing.com India
Theravance (NASDAQ: TBPH) Sets Ampreloxetine Call on Phase 3 Data Expected in Q1 - Stock Titan
Is Theravance Biopharma Inc. (0TB) stock a fit for income portfoliosJuly 2025 Review & Technical Analysis for Trade Confirmation - newser.com
How Theravance Biopharma Inc. (0TB) stock reacts to fiscal policiesWeekly Profit Report & Long-Term Safe Return Strategies - newser.com
Theravance Biopharma Inc. stock trendline breakdownQuarterly Profit Report & Accurate Technical Buy Alerts - newser.com
Is Theravance Biopharma Inc. stock cheap at current valuation2025 Volume Leaders & Weekly Return Optimization Alerts - newser.com
Will a bounce in Theravance Biopharma Inc. offer an exit2025 Biggest Moves & Free High Accuracy Swing Entry Alerts - newser.com
Can Theravance Biopharma Inc. stock deliver consistent earnings growthQuarterly Performance Summary & Reliable Price Breakout Signals - newser.com
Theravance Biopharma Inc. stock retracement – recovery analysisTrade Risk Assessment & Low Volatility Stock Suggestions - newser.com
Theravance Biopharma (NASDAQ: TBPH) to Join Evercore, Oppenheimer Investor Conferences - Stock Titan
News impact scoring models applied to Theravance Biopharma Inc.Earnings Overview Summary & AI Driven Price Predictions - newser.com
What momentum shifts mean for Theravance Biopharma Inc.2025 Earnings Impact & Technical Entry and Exit Tips - newser.com
Comparing Theravance Biopharma Inc. in custom built stock radarsTake Profit & Weekly High Conviction Trade Ideas - newser.com
Can Theravance Biopharma Inc. (0TB) stock hit consensus price targetsJuly 2025 Breakouts & Expert-Curated Trade Recommendations - newser.com
What indicators show strength in Theravance Biopharma Inc.2025 EndofYear Setup & Expert Verified Movement Alerts - newser.com
BTIG Hosts Virtual Meeting Featuring (TBPH) on November 24 - GuruFocus
Why Theravance Biopharma Inc. (0TB) stock benefits from AI revolutionJuly 2025 Update & High Yield Stock Recommendations - newser.com
Theravance Biopharma Inc Azioni (TBPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):